Cytosorbents Financial Overview
Cytosorbents's market cap is currently $41.24M. The company's EPS TTM is $-0.04; its P/E ratio is ―; Cytosorbents is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
